Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-Current Assets (2016 - 2025)

iBio (IBIO) has disclosed Non-Current Assets for 15 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 18.04% to $11.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.8 million, a 4.61% decrease, with the full-year FY2025 number at $13.5 million, up 3.08% from a year prior.
  • Non-Current Assets was $11.0 million for Q4 2025 at iBio, down from $13.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $59.0 million in Q4 2021 to a low of $11.0 million in Q4 2025.
  • A 5-year average of $25.0 million and a median of $14.5 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 70.76% in 2021, then crashed 76.99% in 2022.
  • iBio's Non-Current Assets stood at $59.0 million in 2021, then plummeted by 76.99% to $13.6 million in 2022, then grew by 5.59% to $14.3 million in 2023, then fell by 6.36% to $13.4 million in 2024, then decreased by 18.04% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Non-Current Assets are $11.0 million (Q4 2025), $13.4 million (Q3 2025), and $13.5 million (Q2 2025).